Famke Schneiders

DR.

20112018
If you made any changes in Pure these will be visible here soon.

Research Output 2011 2018

  • 19 Article
  • 2 Chapter
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam
Filter
Article
2017

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

de Bruin, R. C. G., Veluchamy, J. P., Lougheed, S. M., Schneiders, F. L., Lopez-Lastra, S., Lameris, R., Stam, A. G., Sebestyen, Z., Kuball, J., Molthoff, C. F. M., Hooijberg, E., Roovers, R. C., Santo, J. P. D., van Bergen en Henegouwen, P. M. P., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 17 Oct 2017, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticleAcademicpeer-review

2015

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells

Schneiders, F. L., Huijts, C. M., Mantici, A., Menks, M. A. C., Scotet, E., Veerhuis, R., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2015, In : Clinical Immunology. 158, 1, p. 92-99

Research output: Contribution to journalArticleAcademicpeer-review

2014

Bispecific antibody platforms for cancer immunotherapy

Lameris, R., de Bruin, R. C. G., Schneiders, F. L., Henegouwen, P. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Critical Reviews in Oncology / Hematology. 92, 3, p. 153-165

Research output: Contribution to journalArticleAcademicpeer-review

CD1d-Restricted Antigen Presentation by V gamma 9V delta 2-T Cells Requires Trogocytosis

Schneiders, F. L., Prodohl, J., Ruben, J. M., O'Toole, T. G., Scheper, R. J., Bonneville, M., Scotet, E., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Cancer Immunology Research. 2, 8, p. 732-740

Research output: Contribution to journalArticleAcademicpeer-review

Exploiting theCD1d-iNKT cell axis for potentiation of DC-based cancer vaccines

Lameris, R., Schneiders, F. L., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Methods in Molecular Biology. 1139, p. 155-165

Research output: Contribution to journalArticleAcademicpeer-review

Vgamma9Vgamma2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

Werter, I. M., Schneiders, F. L., Scotet, E., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : OncoImmunology. 3, 9, e955343.

Research output: Contribution to journalArticleAcademicpeer-review

2012

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α

Schneiders, F. L., de Bruin, R. C. G., Santegoets, S. J. A. M., Bonneville, M., Scotet, E., Scheper, R. J., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Clinical Immunology. 142, 2, p. 194-200

Research output: Contribution to journalArticleAcademicpeer-review

An alpha-galactosylceramide nose job shapes up iNKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 20-21

Research output: Contribution to journalArticleAcademicpeer-review

An α-galactosylceramide nose job shapes up iNKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., Jan 2012, In : Immunotherapy. 4, 1, p. 20-1 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

Bulldozing Beta-linked glycolipids for recognition by invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 20-20

Research output: Contribution to journalArticleAcademicpeer-review

Bulldozing β-linked glycolipids for recognition by invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., Jan 2012, In : Immunotherapy. 4, 1, p. 20

Research output: Contribution to journalArticleAcademicpeer-review

Gram-positive bacteria: a major microbial 'turn-on' for invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 19-19

Research output: Contribution to journalArticleAcademicpeer-review

2011

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Schneiders, F. L., Scheper, R. J., von Blomberg, B. M. E., Woltman, A. M., Janssen, H. L. A., van den Eertwegh, A. J. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2011, In : Clinical Immunology. 140, 2, p. 130-141

Research output: Contribution to journalArticleAcademicpeer-review

Nuancing the proposed role of NKT cells in aging

Schneiders, F. L., de Bruin, R., Exley, M. A. & van der Vliet, J. J., 2011, In : Virulence. 2, 2, p. 170-170

Research output: Contribution to journalArticleAcademicpeer-review

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin

Schneiders, F. L., van den Berg, H. P., Peters, G. J., Verheul, H. M. W. & van der Vliet, J. J., 2011, In : Medical Oncology. 28, 4, p. 1136-1139

Research output: Contribution to journalArticleAcademicpeer-review